SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-010473
Filing Date
2019-02-14
Accepted
2019-02-14 21:06:25
Documents
1
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 2418
  Complete submission text file 0001209191-19-010473.txt   3785
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address
SEGALL JUDITH (Reporting) CIK: 0001054745 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-38519 | Film No.: 19609579

Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-521-3390
AgeX Therapeutics, Inc. (Issuer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations